rs878853671
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000136.3(FANCC):c.29dupG(p.Cys10TrpfsTer2) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C10C) has been classified as Likely benign.
Frequency
Consequence
NM_000136.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group CInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- colorectal cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- malignant pancreatic neoplasmInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- ovarian cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FANCC | NM_000136.3 | c.29dupG | p.Cys10TrpfsTer2 | frameshift_variant | Exon 2 of 15 | ENST00000289081.8 | NP_000127.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Fanconi anemia Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, truncating variants in FANCC are known to be pathogenic (PMID: 17924555). This sequence change inserts 1 nucleotide in exon 2 of the FANCC mRNA (c.29dupG), causing a frameshift at codon 10. This creates a premature translational stop signal (p.Cys10Trpfs*2) and is expected to result in an absent or disrupted protein product. -
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); Has not been previously published as pathogenic or benign to our knowledge -
Fanconi anemia complementation group C Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.29dupG pathogenic mutation, located in coding exon 1 of the FANCC gene, results from a duplication of G at nucleotide position 29, causing a translational frameshift with a predicted alternate stop codon (p.C10Wfs*2). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at